These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 91696)

  • 1. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract]   [Full Text] [Related]  

  • 7. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
    Novikov DK; Borisenko ID; Shein IA
    Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
    Zöller M; Matzku S; Schulz U; Price MR
    J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    Surg Forum; 1978; 29():167-9. PubMed ID: 233830
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Tumor-associated antigen in female and male breast cancer.
    Perlin E; McCoy JL; Dean JH; Herberman RB
    N Engl J Med; 1975 Jan; 292(1):45-6. PubMed ID: 1109190
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to demonstrate tumour-specific leucocyte migration inhibition in vitro by cryostat sections of breast cancer tissue.
    Petrini B; Bergstrand A; Wasserman J; Blomstedt B; Blomgren H; Baral E
    Clin Oncol; 1977 Sep; 3(3):259-66. PubMed ID: 912961
    [No Abstract]   [Full Text] [Related]  

  • 15. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
    Emmrich F; Ambrosius H
    Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formalinized tumour cells in the leucocyte migration inhibition test.
    Ross CE; Cochran AJ; Hoyle DE; Grant RM; Mackie RM
    Clin Exp Immunol; 1975 Oct; 22(1):126-32. PubMed ID: 1212813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
    Kochetkova VA
    Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
    [No Abstract]   [Full Text] [Related]  

  • 20. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.